[HTML][HTML] Donor clonal hematopoiesis and recipient outcomes after transplantation
CJ Gibson, HT Kim, L Zhao, HM Murdock… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Journal of Clinical Oncology, 2022•ncbi.nlm.nih.gov
PURPOSE Clonal hematopoiesis (CH) can be transmitted from a donor to a recipient during
allogeneic hematopoietic cell transplantation. Exclusion of candidate donors with CH is
controversial since its impact on recipient outcomes and graft alloimmune function is
uncertain.
allogeneic hematopoietic cell transplantation. Exclusion of candidate donors with CH is
controversial since its impact on recipient outcomes and graft alloimmune function is
uncertain.
Abstract
PURPOSE
Clonal hematopoiesis (CH) can be transmitted from a donor to a recipient during allogeneic hematopoietic cell transplantation. Exclusion of candidate donors with CH is controversial since its impact on recipient outcomes and graft alloimmune function is uncertain.
ncbi.nlm.nih.gov